These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9075111)

  • 21. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
    Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
    Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs.
    Patrignani P; Panara MR; Sciulli MG; Santini G; Renda G; Patrono C
    J Physiol Pharmacol; 1997 Dec; 48(4):623-31. PubMed ID: 9444611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New NSAIDs and gastroduodenal damage.
    Folco GC
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-steroidal antiinflammatory drug--management of gastrointestinal complications and inhibition of COX-2].
    Tada Y; Nagasawa K
    Nihon Rinsho; 1999 Feb; 57(2):419-24. PubMed ID: 10078017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective cyclooxygenase-2 inhibition: biological and clinical effects.
    Conti F; Spinelli FR; Ossandon A; Valesini G
    Isr Med Assoc J; 2000 Nov; 2(11):841-7. PubMed ID: 11344755
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells.
    Pilbeam CC; Fall PM; Alander CB; Raisz LG
    J Bone Miner Res; 1997 Aug; 12(8):1198-203. PubMed ID: 9258749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The analysis of nonsteroidal antiinflammatory drug selectivity in prostaglandin G/H synthase (PGHS)-null cells.
    Kirtikara K; Swangkul S; Ballou LR
    Inflamm Res; 2001 Jun; 50(6):327-32. PubMed ID: 11475335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase 2 and the kidney.
    Breyer MD; Harris RC
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):89-98. PubMed ID: 11195058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prime suspect.
    Manuel J
    Environ Health Perspect; 1997 Jan; 105(1):28-9. PubMed ID: 9074875
    [No Abstract]   [Full Text] [Related]  

  • 32. COX-2 inhibitors and the kidney.
    Appel GB
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S37-40. PubMed ID: 11695250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA; Dubois RN
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent development of selective cyclooxygenase-2 inhibitors].
    Kawai S
    Nihon Rinsho; 2002 Dec; 60(12):2370-7. PubMed ID: 12510364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms underlying suppression of lymphocyte responses by nonsteroidal antiinflammatory drugs.
    Rossi Paccani S; Boncristiano M; Baldari CT
    Cell Mol Life Sci; 2003 Jun; 60(6):1071-83. PubMed ID: 12861376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ; Halton DE; Hague A; Paraskeva C
    Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
    Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS
    Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms.
    Venturini CM; Isakson P; Needleman P
    Curr Opin Nephrol Hypertens; 1998 Jan; 7(1):79-82. PubMed ID: 9442367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.